Iterum Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 12, 2021

NEXT STORY
Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection
PREV STORY
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update

SEATTLE and SOUTH SAN FRANCISCO, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), ...

author_avatar
NASDAQ Market News

Arch Biopartners Provides Toxicology Update for Metablok

TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) ...

author_avatar
NASDAQ Market News

Kitov Announces Settlement Agreement with Minority Shareholder of Recently Acquired TyrNovo

TEL AVIV, Israel, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) ...

author_avatar
NASDAQ Market News